Medical Services International Inc. Opens New Division
25 Octobre 2006 - 8:05PM
PR Newswire (US)
EDMONTON, Alberta, Oct. 25 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
it has opened a new division for the regulatory testing and
clinical trials of new products. With plants in India, New Jersey,
Nigeria, China and the Caribbean, Medical Services is ideally
located to offer services related to testing of products and
clinical trials to companies who do not have the staff or
facilities to complete them or companies who require independent
testing. In addition to the testing, with its distribution network
the company can bring products to the market for these companies.
The Company has already agreed to handle the testing of products
for a New Jersey based company. The testing of these products is
expected to start in November 2006. In addition, the Company has
been approached and is negotiating with a biotech corporation to
handle a portion of the testing that is being completed on their
product. The Company anticipates that it will participate in at
least two sets of testing in the next year generating in excess of
$4.0 U.S. million in revenue. This diversification will make sure
that the Company maintains its cash flow regardless of the market
conditions. The Company continues to expand its VScan operation by
increasing its distributors and regulatory approvals in additional
countries. The distributors are actively marketing the VScan
product wherever it has been approved. About VScan The VScan rapid
test kit is a single use, easy to use, cost effective test for HIV
1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West
Nile, Malaria and Prostate Cancer. The kits cannot be sold in
Canada. Medical Services International Inc. trades in the United
States on the NQB Pinksheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or at
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright